Roche May Sell Glucose Meter Business Unit

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the industry grapples with increased competition and reimbursement pressure. The discussions about a potential sale of the Roche unit are still in their early stages and a deal may not materialize, one of the people said. Earlier this year, the Centers for Medicare & Medicaid Services announced it was cutting the reimbursement for diabetes test supplies by up to 72 percent. That would make it more difficult for companies to be profitable in this space, said another of the sources. The change takes effect July 1.

Help employers find you! Check out all the jobs and post your resume.

Back to news